alexa Predictive Diagnostic Tools for the Development of New
ISSN: 2161-0991

Journal of Transplantation Technologies & Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Predictive Diagnostic Tools for the Development of New Onset Diabetes Mellitus after Transplantation: An Overview

Phuong-Thu T Pham1* and Phuong-Chi T Pham2

1Department of Medicine, Nephrology Division, Kidney Transplant Program, David Geffen School of Medicine at UCLA, Los Angels, CA 90095

2Department of Medicine, Nephrology Division, UCLA-Olive View Medical Center, Sylmar, CA 91342

*Corresponding Author:
Phuong-Thu T Pham
Clinical Associate Professor of Medicine
Director of Outpatient Services
Department of Medicine, Nephrology Division
Kidney Transplant Program
David Geffen School of Medicine at UCLA, Los Angeles, CA 90095
E-mail: [email protected]

Received Date: July 25, 2011; Accepted Date: August 02, 2011; Published Date: September 26, 2011

Citation: Pham PT, Pham PC (2011) Predictive Diagnostic Tools for the Development of New Onset Diabetes Mellitus after Transplantation: An Overview. J Transplant Technol Res 1: 103e. doi: 10.4172/2161-0991.1000103e

Copyright: © 2011 Pham PT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



New onset diabetes mellitus after transplantation (NODAT) is a serious and common complication following solid organ transplantation. NODAT has been reported to occur in 2% to 53% of all solid organ transplants. Kidney transplant recipients who develop NODAT have variably been reported to be at increased risk of fatal and nonfatal cardiovascular events and other adverse outcomes including infection, reduced patient survival, graft rejection, and accelerated graft loss compared with those who do not develop diabetes. Limited clinical studies in liver, heart, and lung transplants similarly suggested that NODAT has an adverse impact on patient and graft outcomes. Early detection and management of NODAT must, therefore, be integrated into the treatment of transplant recipients. Studies investigating the best predictive tool for identifying patients at risk for developing NODAT early after transplantation, however, are lacking. The clinical predictive values of fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), and A1C in assessing the risk for the manifestation of NODAT are herein discussed.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version